申请人:Holsinger Leslie Jean
公开号:US20090270415A1
公开(公告)日:2009-10-29
The present invention is directed to compounds that have the dual property of acting as cathepsin S inhibitors and of inhibiting HCV replication. Such compounds are therefore useful in treating disease states that include hepatitis C, Alzheimer's disease, and autoimmune disorders. The present invention is also directed to pharmaceutical compositions containing these compounds, and processes for preparing the compounds.
本发明涉及具有双重性质的化合物,既具有作为蛋白酶S抑制剂的作用,又具有抑制HCV复制的作用。因此,这些化合物对治疗包括丙型肝炎、阿尔茨海默病和自身免疫性疾病等疾病状态有用。本发明还涉及含有这些化合物的制药组合物以及制备这些化合物的过程。